CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Biogen Inc. (NASDAQ:BIIB) today announced it will report third quarter 2017 financial results on Tuesday, October 24, 2017, before the financial markets open.
Following the release of the financials, the Company will host a live webcast with Biogen management from 8:30-9:30 am ET. To access the live webcast, please go to the investor relations section of Biogen’s website at www.biogen.com/investors. Following the live webcast, an archived version of the call will be available at the same URL.
About Biogen
Through cutting-edge science and medicine,
Biogen discovers, develops and delivers innovative therapies worldwide
for people living with serious neurological and neurodegenerative
diseases. Founded in 1978, Biogen is a pioneer in biotechnology and
today the Company has the leading portfolio of medicines to treat
multiple sclerosis, has introduced the first and only approved treatment
for spinal muscular atrophy, and is at the forefront of neurology
research for conditions including Alzheimer’s disease, Parkinson’s
disease and amyotrophic lateral sclerosis. Biogen also manufactures and
commercializes biosimilars of advanced biologics. For more information,
please visit www.biogen.com.
Follow us on social media – Twitter,
LinkedIn,
Facebook,
YouTube.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170926006486/en/
